| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/13/2004 | EP1466178A1 Screening methods and the use of agents identified using the same |
| 10/13/2004 | EP1466175A2 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 10/13/2004 | EP1466174A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 10/13/2004 | EP1466017A2 Tissue rejection |
| 10/13/2004 | EP1465998A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465996A2 Raf/ras binding compounds |
| 10/13/2004 | EP1465995A1 Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same |
| 10/13/2004 | EP1465990A2 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 10/13/2004 | EP1465927A2 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465923A1 Corticotropin releasing factor receptor 2 agonists |
| 10/13/2004 | EP1465922A2 Corticotropin releasing factor receptor 2 agonists |
| 10/13/2004 | EP1465921A2 Corticotropin releasing factor receptor 2 agonists |
| 10/13/2004 | EP1465918A2 Peptides promoting cell adherence, growth and secretion |
| 10/13/2004 | EP1465916A2 Novel g proein-coupled receptor, gave7 |
| 10/13/2004 | EP1465912A2 Novel chimeric tnf ligands |
| 10/13/2004 | EP1465910A2 Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid |
| 10/13/2004 | EP1465909A2 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof |
| 10/13/2004 | EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins |
| 10/13/2004 | EP1465905A2 Antisense modulation of myd88 expression |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465866A2 Protease inhibitors of the coagulation cascade isolated from dysidea sponges |
| 10/13/2004 | EP1465863A1 Potassium channel modulators |
| 10/13/2004 | EP1465656A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 10/13/2004 | EP1465654A2 Plasmid mediated suplementation for treating chronically ill subjects |
| 10/13/2004 | EP1465653A1 Therapeutic application of g-csf, gm-csf and scf |
| 10/13/2004 | EP1465652A2 Povidone-containing carriers for polypeptide growth factors |
| 10/13/2004 | EP1465651A1 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer |
| 10/13/2004 | EP1465650A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders |
| 10/13/2004 | EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase |
| 10/13/2004 | EP1465643A1 Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 10/13/2004 | EP1465634A2 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 10/13/2004 | EP1465633A1 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1465592A2 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 10/13/2004 | EP1465578A2 Antisense modulation of vascular endothelial growth factor receptor-1 expression |
| 10/13/2004 | EP1465558A2 Methods, devices, and preparations for intervertebral disc treatment |
| 10/13/2004 | EP1465521A2 System and method for the pretreatment of the endplates of an intervertebral disc |
| 10/13/2004 | EP1465493A1 Cultured and encapsulated pancreatic stem cells |
| 10/13/2004 | EP1397106A4 Dental restorative materials |
| 10/13/2004 | EP1361897A4 Methods for inhibiting pain |
| 10/13/2004 | EP1313510B1 Injectable pharmaceutical composition for systemic delivery of pharmacologically active compounds comprising medium chain triglycerides |
| 10/13/2004 | EP1313500B1 Combinations of dalfopristine/quinupristine with cefpirome |
| 10/13/2004 | EP1280820B1 Anti-inflammatory compounds and uses thereof |
| 10/13/2004 | EP1250095B1 Versatile hydrophilic dyes |
| 10/13/2004 | EP1203014B1 Peptide antagonists of factor viia |
| 10/13/2004 | EP1154786B1 Compositions for altering mucus secretion |
| 10/13/2004 | EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 10/13/2004 | EP1102763B1 Fsh mimetics for the treatment of infertility |
| 10/13/2004 | EP1093383B1 Drug delivery system comprising a homeobox peptide and a cytotoxic or antineoplastic drug |
| 10/13/2004 | EP1062230B1 Method for increasing the serum half-life of a biologically active molecule |
| 10/13/2004 | EP1053027B1 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi |
| 10/13/2004 | EP1012291B1 Multiple site delivery of adenoviral vector for the induction of angiogenesis |
| 10/13/2004 | EP0973818B1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same |
| 10/13/2004 | EP0921821B1 2-methoxyestradiol-induced apoptosis in cancer cells |
| 10/13/2004 | EP0876402B1 Growth hormone secretagogue receptor family |
| 10/13/2004 | EP0873136B1 High fluorescence specific immune enhancing factor and methods of use for same |
| 10/13/2004 | EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 10/13/2004 | EP0839155B1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 10/13/2004 | EP0817847B1 Il-17 receptor |
| 10/13/2004 | EP0736036B1 Kininogen inhibitors |
| 10/13/2004 | EP0719147B1 Gene therapy for solid tumors, papillomas and warts |
| 10/13/2004 | EP0652975B1 Assessment of trans-acting factors allelic variation |
| 10/13/2004 | EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 10/13/2004 | CN1537167A Von willebrand factor (VWF)-cleaving enzyme |
| 10/13/2004 | CN1537117A 干扰素γ多肽变体 IFN-γ polypeptide variant |
| 10/13/2004 | CN1537017A Remedie for inflammatory bowel diseases |
| 10/13/2004 | CN1537014A HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases |
| 10/13/2004 | CN1537012A Use of long pentraxin PTX3 for treatment of FGF-3 mediated tumour diseases |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1536998A Integrin inhibitors for treatment of eye diseases |
| 10/13/2004 | CN1536995A Antitumor compositions containing taxane derivatives |
| 10/13/2004 | CN1536994A Hypoglycemic agent |
| 10/13/2004 | CN1536967A Nutritional composition preventing bacterial overgrowth |
| 10/13/2004 | CN1536083A Low virulent vero strain |
| 10/13/2004 | CN1536079A 修饰的精氨酸脱亚氨酶 Modified arginine deiminase |
| 10/13/2004 | CN1536078A Preparation method of recombinant can diad urate oxidase |
| 10/13/2004 | CN1535986A Blood substitute prepared by using hematoglobin-human seralbumin conjugate and its preparation method |
| 10/13/2004 | CN1535983A Blood vessel generating inhibitor |
| 10/13/2004 | CN1535981A Peptide capable of lyzing pathogen and its application |
| 10/13/2004 | CN1535980A New compound with cativity for inhibiting glycine transport factor |
| 10/13/2004 | CN1535728A Drug composition for curing disease produced from IL-6 |
| 10/13/2004 | CN1535727A Mixed polypeptide vaccine, its preparation and application |
| 10/13/2004 | CN1535724A New application of recombinant human interferon for preventing serious acute respiratory tract syndrome |
| 10/13/2004 | CN1535723A Extraction and application of cell growth promoting peptid orjgenated from silk protein |
| 10/13/2004 | CN1535722A Colostrum peptide and its application |
| 10/13/2004 | CN1535681A Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal |
| 10/13/2004 | CN1170936C Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities |
| 10/13/2004 | CN1170933C Motilin homologs |
| 10/13/2004 | CN1170931C Vasculogenesis correlation molecule |
| 10/13/2004 | CN1170929C Human protein able to suppress growth of cancer cells and its coding sequence |
| 10/13/2004 | CN1170927C Method for producing medicine using silkworm expressed numan epidermal growth factor |
| 10/13/2004 | CN1170850C Human angiogenin-like protein and coding sequence and application thereof |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170848C Novel human hepatoma associated protein and coding sequence thereof |
| 10/13/2004 | CN1170844C Human macrobiosis-ensuring protein and its coding sequence and application |
| 10/13/2004 | CN1170842C New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 10/13/2004 | CN1170832C Substituted thiazol [3,2-alphal]azatropylidene derivatives |